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Abstract: It is common to find Competitive Intelligence activities within the high-
tech enterpnses in particular in the pharmaceutical industry. These companies not 
only use the process of Competitive Intelligence (CI) to act against competitors, 
traditional aim of the CI. It is increasingly used to enhance cooperation. The cycle 
of CI is used both as to extract offensive and defensive intelligence as cooperative 
intelligence. The paper presents the results of a sample study of 186 Spanish 
pharmaceutical companies that were asked about the purpose of cooperation in 
their CI activities. The results confirm that these are used in the development of 
business relationships, search for partners, joint research, etc. and that companies 
bet on these relationships for the future within the CI. 
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1 Introduction 
Competitive intelligence (CI) is one of the most useful tools for strategic analysis 
because it provides, analyses and distributes information, the knowledge and intel-
ligence throughout the organization. The importance given to CI has been based 
on offensive and defensive activities implemented in the company. However, 
some authors have opened another research line that creates tools to make deci-
sions in other directions. Thus, sometimes the company launches its CI to research 
the environment and competition in particular with the aim to enhance internal 
improvements or collaborations with companies (e.g. for open innovation lines). 
The Medical College Organisation report (OMC) on the pharmaceutical sector 
(OMC, 2014) some actions are recommended to increase the competitiveness of 
the sector. The OMC says that it would be reasonable to expect a process of con-
centration and restructuring that promotes partnerships, joint ventures or mergers 
to créate solvent and innovative pharmaceutical companies. It is noteworthy that 
the research model of the pharmaceutical industry continúes to evolve over the last 
decade, from the classic pattern of R&D to prototype called R&C (cooperation 
and / or collaboration). 
In this sense, the goal of the study is to analyse the behaviour of pharmaceutical 
companies integrated in the Farmaindustria association with the possibility to im-
prove the cooperation amongst them by using CI cycle activities. Five phases are 
suggested in the process of CI generation to study in each of them the importance 
of cooperation. The aim is to determine whether cooperation is a purpose in using 
the CI in a company and, if so, we can expect CI processes to evolve and enhance 
the relationship networks between companies in the sector. 
2 Theoretical Considerations 
The Strategic and Competitive Intelligence Professionals (SCIP) describes com-
petitive intelligence as "the process of gathering ethically, analysis and dissemi-
nate reliable, relevant, specific intelligence, timely, foresighted and actionable, re-
garding the implications of the business environment the competitors and the 
organization itself" (SCIP, 1999). However, there are many CI definitions provid-
ed by different authors remarking the strategic aspect and the variety of targets 
with their activities (Cohén, 1997; McGonagle, 1998; Bernhardt, 1994; Hockman, 
1999). The information provided to the organization by the CI, properly treated, 
generates intelligence on which to base strategic planning and decisión making 
and with an impact on organizational performance (Prescot, 1999; Herring, 1999 
Ortoll and others, 2010; Antia and Hesford, 2007, Tena and Comai, 2003). 
There is currently no data in literature on the number of companies carrying out 
competitive intelligence as a systemic process. Studies in Spain (Postigo, 2001; 
Infoact, 2001; Cetisme, 2003; Tena and Comai, 2003) cannot detail the spread of 
practice in companies due to the heterogeneity of the analysed organizations. 
2.1. CI Cicle 
Despite the virtual unanimity on the scientific method being the precedent of the 
intelligence cycle (Vignettes, 2010), we can say that there has never been agree-
ment on the number, ñame and specific content of the phases comprising it. How-
ever, when analysing the mentioned characteristics and phases, we find in litera-
ture some common trends in different authors and communities as well as 
important differences between them. It is noteworthy that the positions are not 
contradictory but complementary (Bernhardt, 1994; Ortoll et al, 2010; Prescott, 
1999; Choo, 2002; Lesea, 2006; Arroyo, 2005; Martinet and Marti, 1995; Escorsa 
and Maspons, 2001; Ashtonand Stacey, 1995). 
On this basis, the proposed CI is formed by five phases (Figure 1): Planning of 
resources and activities; Collection and validation of information; Analysis and 
dissemination of intelligence; Using the results; and Evaluation of process perfor-
mance. 
Fig. 1: Competitive Intelligence Cycle of five phases 
2.1.1 Planning of resources and activities 
Companies need to plan the CI activities bearing in mind the final aim. Sometimes 
planning needs legal information, tax rate, etc; others it needs information from 
competitors to know what they are and their activities in the sector. In other occa-
sions the priority is in the information on market changes, producís and processes, 
etc. 
2.1.2 Collection and validation of information 
At this stage of CI companies evalúate where and under what conditions gather 
the necessary information to fulfil their need. Therefore, it is mandatory to know 
the sources of such information (internal, external, prívate, public, structured, un-
structured, etc.) It is also important to know the existence of controls, validation 
and verification of sources and information. 
2.1.3 Analysis and dissemination of intelligence 
At this stage of the process the tools used for data analysis, analysis and control of 
both the information storage and the needed and generated, are of great im-
portance. The different ways to broadcast or disseminate the intelligence generat-
ed in the organization can be carried out by taking into account individuáis or spe-
cific group departments (marketing, R&D&I, sales network, general management, 
etc.), users subsidiaries or from within the organization. It is also important to 
know the kind of dissemination that is carried out from the media's point of view 
(meetings, intranet or other). 
2.1.4 Using the results 
At this stage it is important to remark the activities focused to sort out problems 
and analyse whether the company is aware that the CI has managed to solve risky 
situations in departments, subsidiaries, projects, etc., and if it is expected that the 
results of the CI serve to sort out different issues. 
2.1.5 Evaluation of process performance 
Companies should evalúate the results of the CI cycle to enable process improve-
ment and the necessary adjustments on the planned targets. It is necessary to eval-
úate activities flexibility, CI user's satisfaction, improvements inthe strategic are-
as of the organization, etc. 
2.2 Cooperation and CI 
Information has a first magnitude strategic dimensión, either as active means of 
defense -knowing to prevent- or reactive -knowing to attack (Kahn, 2001). How-
ever, authors like Ortoll et al (2010) confirm that the impact of social networks on 
both information sources and the efficiency of the whole process of competitive 
intelligence is significant. Thus, several authors have explored the importance of 
social networks in the process of competitive intelligence (Palop and Vicente, 
1999; Escorsa and Maspons 2001; Trim, 2004; Michaeli, 2006), especially the im-
portance of networks as sources of information for their members. Some research-
ers also relate the involvement of network structure on the efficiency of the pro-
cess of CI (Jaworski and Kohli Macinnis, 2002). 
This job has planned a model that, just as others (Tena and Comai, 2001; Hus-
sey and Jenster, 1999) takes into account the purpose of the CI in the company. 
Two objectives are proposed in the activities of the CI cycle. The company may 
determine that part or the whole of the CI activity pursue the so called competitor 
intelligence (for defensive and offensive actions) and can determine how much of 
the CI is intended for a cooperative intelligence. There is wide reference of com-
petitor intelligence in literature due to the CFs own nature, but it is harder to find 
evidence of the second, competitive intelligence for cooperation, partner search, 
agreements, etc. However, activities taking place in the CI cycle can be used in a 
broad spectrum of fundamental issues for the development of a partnership (fi-
nance, marketing, R&D&I, etc.). 
3 Method 
This job applies a descriptive and explanatory method based on a questionnaire 
addressed to analyse the CI phases, the targets pursued by the company and the 
impact on some business results. A sample of the sector the National Business As-
sociation of the Pharmaceutical Industry (Farmaindustria ) established in Spain 
was taken to carry out this study. The group has the vast majority of pharmaceuti-
cal laboratories (186 members representing 84% of the prescription market and 
42% of the holders of marketing authorizations for medicines). The final ques-
tionnaire was obtained after several meetings with industry experts (managers, la-
boratory owners) área doctors of the company organisation and the sub-
department of Farmaindustria. After validating the questionnaire it was sent to all 
partners in Farmaindustria guaranteeing the confidentiality of responses 
It is important to remark the existing difficulty to draw information from these 
companies. You have to go through many different filters in order that pharmaceu-
tical companies consider it innocuous to answer questions on the information they 
use. In most cases legal departments should approve the questionnaires and this 
may take weeks. 
The five CI phases compiling the theory bases of the different authors were laid 
out. At each stage of the CI cycle, laboratones were asked for different aspects of 
the interest in cooperation. With the answers to the questionnaire a descriptive 
analysis of the use of CI for cooperation activities and expectations of pharmaceu-
tical companies was carried out. 
4 Results 
The results are divided according to the five phases of the CI cycle. In the plan-
ning phase 65 % of companies stated that they commonly use CI Consulting when 
cooperation activities are intended. Given the competitive nature of the CI it 
seems that, as stated by Tena and Comai (2001), the cooperative intelligence has 
significant purposes for the process. 
During the second stage, information collection phase, over 50 % of companies 
answer that they commonly use sources of information from their partners in re-
search projects. That shows the level of relationship that come to have companies 
so protective towards the security of their information when it comes to investí-
gate with other companies. There are also a high percentage of companies using 
information from other subsidiaries of the group at times or on many occasions. 
Bearing in mind they were asked in the context of CI, it is noteworthy that the 
percentages of consultation between partners and between subsidiaries of the same 
group are not far. 
In the third phase of the CI cycle, companies declared that 40% send relevant 
information to the project partners, while only 6.4 % do so to their own subsidiar-
ies. It is remarkable the importance given to the management of information be-
tween partners when having a common project. It should be noted that they were 
not asked for a specific project, but for their usual performance in the context of 
CI. 
The fourth phase, referring to the use of the results, it is noted that 66 % of cas-
es frequently use the reports generated in CI in other companies of the same 
group, but not a regular system as only 10% do so. In both situations described 
usage decreases when asked for external companies in the same group. Using CI 
reports between project partners is also important (40 % of respondents), whilst 
almost 39% never or almost never used them. 
The last phase, performance evaluation, reveáis that pharmaceutical companies 
consider that CI encourages collaboration with other organisations (over 60 % 
agree or strongly agree with this). Regarding the detection of new financial part-
ners approximately 30% said that the CI was not relevant or had minor im-
portance, but 50% said it was quite or very important. 
Finally, as to the intention to increase CI resources, willingness was shown to 
increase resources in the pharmaceutical sector, regardless the current economic 
situation. 
5 Conclusions 
Farmaindustria's pharmaceutical companies show that they commonly use other 
companies' sources of information, they share the knowledge gained in the CI 
process with project partners and consider that the CI encourages collaboration 
with other entities. It should be noted that they were not asked for a specific pro-
ject but by the usual action for cooperation in the framework of CI. 
The main conclusión is that most pharmaceutical companies are committed to 
sharing knowledge generated during the CI process with other companies, subsid-
iarles or partners despite such tight controls imposed in the sector when it comes 
to extracting information in their organizations. 
In general, there was a willingness to increase the resources invested in CI in 
the pharmaceutical sector. It seems that if we bet for cooperation, companies will 
find in the intelligence process a valuable ally to advance towards their research 
objectives and growth. 
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